Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2020 | The pathways of CLL pathogenesis and CLL’s relationship with MBL

Kostas Stamatopoulos • 16 Sep 2020
ERIC 2020
Chronic Lymphocytic Leukemia Leukemia Monoclonal B-Cell Lymphocytosis

Kostas Stamatopoulos, MD, PhD, Center for Research and Technology Hellas, Thermi, Greece, discusses whether there is one or multiple pathways to developing chronic lymphocytic leukemia (CLL). Dr Stamatopoulos also discusses the potential relationship between CLL and monoclonal B-cell lymphocytosis (MBL), and how this can develop our understanding of the disease. This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Kostas Stamatopoulos

3:19
Translating scientific advances into clinical success in CLL: satellite symposium highlights
Kostas Stamatopoulos • 19 Mar 2022
2:02
The link between the tumor microenvironment & gene expression in CLL
Kostas Stamatopoulos • 19 Mar 2022
1:46
Pathogenesis and transformation in CLL: session highlights
Kostas Stamatopoulos • 19 Mar 2022
2:54
The definition of high-risk CLL
Kostas Stamatopoulos • 19 Mar 2022

Related Videos

2:25
Optimizing haplo-SCT for the treatment of AML
Arnon Nagler • 16 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals